Increased protein degradation and decreased protein synthesis in skeletal muscle during cancer cachexia
about
Effect of a tumour-produced lipid-mobilizing factor on protein synthesis and degradationClinical classification of cancer cachexia: phenotypic correlates in human skeletal muscleThe regulation of skeletal muscle protein turnover during the progression of cancer cachexia in the Apc(Min/+) mouse.Induction of cachexia in mice by a product isolated from the urine of cachectic cancer patients.Induction of muscle protein degradation by a tumour factorIncrease in muscle mitochondrial biogenesis does not prevent muscle loss but increased tumor size in a mouse model of acute cancer-induced cachexiaCancer-induced fatigue and skeletal muscle wasting: the role of exercise.Attenuation of muscle atrophy in a murine model of cachexia by inhibition of the dsRNA-dependent protein kinaseEffect of branched-chain amino acids on muscle atrophy in cancer cachexia.Cancer causes cardiac atrophy and autophagy in a sexually dimorphic manner.Expression of NF-kappaB and IkappaB proteins in skeletal muscle of gastric cancer patients.Arginine depletion by arginine deiminase does not affect whole protein metabolism or muscle fractional protein synthesis rate in mice.Genome-wide identification of FoxO-dependent gene networks in skeletal muscle during C26 cancer cachexia.Myosin heavy chain is not selectively decreased in murine cancer cachexiaAnorexia-Cachexia syndrome in cancer: implications of the ubiquitin-proteasome pathway.Mechanisms underlying the anti-wasting effect of L-carnitine supplementation under pathologic conditions: evidence from experimental and clinical studies.Effect of a tumour-derived lipid-mobilising factor on glucose and lipid metabolism in vivo.Omega-3 polyunsaturated fatty acids and cancer: lessons learned from clinical trials.A review of body composition and pharmacokinetics in oncology.A leucine-rich diet modulates the tumor-induced down-regulation of the MAPK/ERK and PI3K/Akt/mTOR signaling pathways and maintains the expression of the ubiquitin-proteasome pathway in the placental tissue of NMRI mice.Molecular mechanism of sarcopenia and cachexia: recent research advances.Heat shock protects L6 myotubes from catabolic effects of dexamethasone and prevents downregulation of NF-kappaB.Mechanisms mediating cancer cachexia.Cleavage of caspases-1, -3, -6, -8 and -9 substrates by proteases in skeletal muscles from mice undergoing cancer cachexia.Expression of the ubiquitin-proteasome pathway and muscle loss in experimental cancer cachexia.Higher skeletal muscle protein synthesis and lower breakdown after chemotherapy in cachectic mice.Association of Weight Change after Colorectal Cancer Diagnosis and Outcomes in the Kaiser Permanente Northern California Population.Complete reversal of muscle wasting in experimental cancer cachexia: Additive effects of activin type II receptor inhibition and β-2 agonist.Inflammatory signalling regulates eccentric contraction-induced protein synthesis in cachectic skeletal muscle.Linking Cancer Cachexia-Induced Anabolic Resistance to Skeletal Muscle Oxidative Metabolism.Preoperative glucose and protein metabolism: the influence of diabetes mellitus type 2 in patients with colorectal tumors.Metabolic Changes During Cancer Cachexia Pathogenesis.Treating cachexia using soluble ACVR2B improves survival, alters mTOR localization, and attenuates liver and spleen responses.The AMPK agonist 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), but not metformin, prevents inflammation-associated cachectic muscle wasting.
P2860
Q28366619-B2F12694-D87C-4C51-81A0-C1CB486017A0Q28538296-972EB833-4E0B-4099-8795-7364DFEFFE70Q34031423-9C8FAFE1-9A5B-4BD4-9CD2-F0BEDE6F9715Q34065192-085B580E-1062-4087-A93A-C2BCD97EB2B3Q34065542-9D585ED8-40D6-4656-ACE7-45C337710D3BQ34200939-C3682081-64C8-4E2E-B5B9-24A3BC393410Q34362661-02143573-2A94-4551-87EA-A196E3FCAB3CQ34578128-F43885FB-1BE9-4931-A1B6-708A33B45C1AQ34580998-29270754-90EE-4108-8A59-6DAB44A73077Q34629952-C0BF0D9C-F07C-43C3-96AD-9925B8290D07Q35111740-D43108E1-E962-4FBE-8114-B0089C612A09Q35182189-F6BD0E99-0768-41D0-9A4C-3F29119D0EA1Q35341311-B419282B-B99A-4CF0-BA6F-3FDA2C0E215DQ35705679-55E28861-5ED4-4FE9-9981-5C11F443F472Q36526950-9AEAAF37-D430-457B-AD03-7BB4DBE15851Q38090981-7A55A48B-176F-41B9-A580-BE969A4D6ED8Q38289950-F40573FC-16FF-4BD9-BDA3-1792C9B55D13Q38557891-243D2A9D-F1BA-4153-A4A5-4C4398138A0EQ38709340-9364D1B8-E870-4D22-A6D1-463B4EB9C46CQ38940463-4801696B-5E5E-4CEB-B9C7-6AE26126A555Q39094397-38096137-A83F-4387-BDA3-D8E3D92356FBQ40780492-ACF197C6-3325-42A3-9218-614784C34D29Q40984036-FF7563CF-2A2A-4D63-BE67-077F94401276Q41831132-43BF4F21-E61E-40A8-AD0E-C7DFA1DA5700Q43200752-88701143-1166-40CC-883A-7FB7385069A9Q43638771-D1EE8F40-2525-4B95-82E2-F95CA7787C1AQ46429494-3CF23308-C659-4FA9-8A61-8C7FFCEA4A89Q46635433-FD69EC87-0FE3-4AE8-8662-6E3A198BDE08Q47320394-ECBF06C8-40E4-45F8-960E-D1C45C323574Q48155681-C48AAD70-0057-478B-91FB-368BB0016039Q48248546-155B729B-D4E1-466F-B1D9-3A5047F1B8A4Q49544329-2BB04B1D-2D09-4A8A-A6E6-4AFA1B19EA08Q55432588-00E9B323-53D8-43EF-9B28-F3DD242A377AQ55653938-491E156F-2A23-4075-BF83-3E21970A6656
P2860
Increased protein degradation and decreased protein synthesis in skeletal muscle during cancer cachexia
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Increased protein degradation ...... muscle during cancer cachexia
@ast
Increased protein degradation ...... muscle during cancer cachexia
@en
type
label
Increased protein degradation ...... muscle during cancer cachexia
@ast
Increased protein degradation ...... muscle during cancer cachexia
@en
prefLabel
Increased protein degradation ...... muscle during cancer cachexia
@ast
Increased protein degradation ...... muscle during cancer cachexia
@en
P2860
P356
P1476
Increased protein degradation ...... muscle during cancer cachexia
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1993.126
P407
P577
1993-04-01T00:00:00Z
P5875
P6179
1030089752